Integral Diagnostics Limited (ASX:IDX)
1.620
-0.030 (-1.82%)
Nov 17, 2026, 11:20 AM AEDT
Integral Diagnostics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $2.51. The average 1-year stock price forecast is 54.63% higher than the current stock price, while the lowest is $1.77 (+9.26%) and the highest is $3.30 (+103.70%).
Price Target: $2.51 (+54.63%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Hold | 1 | 1 | 2 | 2 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Downgrades $1.77 | Hold | Downgrades | $1.77 | +9.26% | Nov 3, 2026 |
| Jefferies | Jefferies | Buy Maintains $3.30 → $2.90 | Buy | Maintains | $3.30 → $2.90 | +79.01% | Oct 30, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains $2.24 → $1.82 | Hold | Maintains | $2.24 → $1.82 | +12.35% | Oct 30, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $3.30 → $2.70 | Buy | Maintains | $3.30 → $2.70 | +66.67% | Oct 30, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $3.20 → $2.80 | Buy | Maintains | $3.20 → $2.80 | +72.84% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
824.75M
from 788.62M
Increased by 4.58%
Revenue Next Year
869.93M
from 824.75M
Increased by 5.48%
EPS This Year
0.11
from 0.13
Decreased by -14.61%
EPS Next Year
0.13
from 0.11
Increased by 21.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.